The amplification and sequencing of the V3-V4 variable region of the bacterial 16S rDNA gene was performed using the Illumina MiSeq platform ... dehydrated through graded ethanol and xylene, and ...

and finally 419 samples were included and subjected to 16S rRNA Miseq sequencing. Participants’ demographics, clinicopathological data, CT scan, histopathology images and diet habit were collected ...

3. New Product Launches: The introduction of the MiSeq i100 series aims to expand Illumina’s total addressable market by making it easier for new NGS customers to enter the market. 4.

3. New Product Launches: The introduction of the MiSeq i100 series aims to expand Illumina’s total addressable market by making it easier for new NGS customers to enter the market. 4. Innovation Focus ...

Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of new partnerships or products, namely the MiSeq i100 benchtop sequencer.

Illumina's commitment to increasing the sustainability of its business and products was further demonstrated in 2024 with the launch of the MiSeq i100 Series, which included key innovations, such as ...

Illumina's commitment to increasing the sustainability of its business and products was further demonstrated in 2024 with the launch of the MiSeq i100 Series, which included key innovations ...

Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

Enabled on Illumina sequencers and a new multimodal analysis platform, Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity.